Header Logo

Connection

YONG LI to Lymphoma, T-Cell

Back to Details
This is a "connection" page, showing publications YONG LI has written about Lymphoma, T-Cell.
YONG LI
Connection Strength
0.193
Lymphoma, T-Cell
  1. CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma. BMC Med. 2023 08 30; 21(1):330.
    View in: PubMed
    Score: 0.193
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.